Zepteon
Stage
Unattributed | AliveTotal Raised
$210KLast Raised
$210K | 8 yrs agoAbout Zepteon
Zepteon has developed an antibody development and manufacturing technology that enables biopharmaceutical companies to evaluate and tune their drug potency. This is accomplished by separating high potency antibodies (nonfucosylated) from complex mixtures using our Glycap-3A chromatography resin. This technology streamlines the regulatory required structure:function characterization activities and enables a new method of drug manufacturing for biosimilars, biobetters and novel therapeutics.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Zepteon Patents
Zepteon has filed 2 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- EC 2.4.1
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/20/2012 | 3/5/2019 | Monoclonal antibodies, Clusters of differentiation, Immune system, Proteins, Immunology | Grant |
Application Date | 7/20/2012 |
|---|---|
Grant Date | 3/5/2019 |
Title | |
Related Topics | Monoclonal antibodies, Clusters of differentiation, Immune system, Proteins, Immunology |
Status | Grant |
Zepteon Frequently Asked Questions (FAQ)
Where is Zepteon's headquarters?
Zepteon's headquarters is located at 42 Chauncy Street, Boston.
What is Zepteon's latest funding round?
Zepteon's latest funding round is Unattributed.
How much did Zepteon raise?
Zepteon raised a total of $210K.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
